中文名 | (4-吡啶-2-苯基)-乙酸 |
---|---|
英文名 | 2-(4-pyridin-2-ylphenyl)acetic acid |
英文别名 | ab1586 |
分子式 | C13H11NO2 |
---|---|
分子量 | 213.23200 |
精确质量 | 213.07900 |
PSA | 50.19000 |
LogP | 2.37570 |
储存条件 | 室温 |
危害码 (欧洲) | Xi |
---|---|
海关编码 | 2933399090 |
~% 51061-67-7 |
文献:AiCuris GmbH and Co. KG; Schwab, Wilfried; Birkmann, Alexander; Vögtli, Kurt; Haag, Dieter Dr.; Lender, Andreas Dr.; Grunenberg, Alfons Dr.; Keil, Birgit D.-I.; Rehse, Joachim Dr. Patent: EP2573086 A1, 2013 ; Location in patent: Paragraph 0070 ; |
~% 51061-67-7 |
文献:AICURIS GMBH and CO. KG; SCHWAB, Wilfried; BIRKMANN, Alexander; VÖGTLI, Kurt; HAAG, Dieter; LENDER, Andreas; GRUNENBERG, Alfons; KEIL, Birgit; REHSE, Joachim Patent: WO2013/45479 A1, 2013 ; Location in patent: Page/Page column 21-22 ; |
~% 51061-67-7 |
文献:Artico; Silvestri; Stefancich; Avigliano; Di Giulio; Maccarrone; Agostinelli; Mondovi; Morpurgo European Journal of Medicinal Chemistry, 1992 , vol. 27, # 3 p. 219 - 228 |
~% 51061-67-7 |
文献:Artico; Silvestri; Stefancich; Avigliano; Di Giulio; Maccarrone; Agostinelli; Mondovi; Morpurgo European Journal of Medicinal Chemistry, 1992 , vol. 27, # 3 p. 219 - 228 |
~% 51061-67-7 |
文献:Artico; Silvestri; Stefancich; Avigliano; Di Giulio; Maccarrone; Agostinelli; Mondovi; Morpurgo European Journal of Medicinal Chemistry, 1992 , vol. 27, # 3 p. 219 - 228 |
~% 51061-67-7 |
文献:AiCuris GmbH and Co. KG; Schwab, Wilfried; Birkmann, Alexander; Vögtli, Kurt; Haag, Dieter Dr.; Lender, Andreas Dr.; Grunenberg, Alfons Dr.; Keil, Birgit D.-I.; Rehse, Joachim Dr. Patent: EP2573086 A1, 2013 ; |
~% 51061-67-7 |
文献:AiCuris GmbH and Co. KG; Schwab, Wilfried; Birkmann, Alexander; Vögtli, Kurt; Haag, Dieter Dr.; Lender, Andreas Dr.; Grunenberg, Alfons Dr.; Keil, Birgit D.-I.; Rehse, Joachim Dr. Patent: EP2573086 A1, 2013 ; |
上游产品 6 | |
---|---|
下游产品 0 |
海关编码 | 2933399090 |
---|---|
中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |